ERBB2 and breast carcinoma: As future prospects for our work, an active immunisation with anti-Id scFv 40 and 69 to prevent the development of tumours in a transgenic mouse model of HER-2/neu mammary tumorigenesis (as a model of human breast cancer) will be performed.